Increasing concentrations of BTP2 and CM4620 resulted in a dose‐dependent suppression of cytokine production in CD4+ and CD8+ effector and effector memory T cells, Th17 cells, as well as Treg cells isolated from the LP of IBD patients. Here, CD4 is linked to inflammatory bowel disease.